No differences in olanzapine- and risperidone-related weight gain between women and men: a meta-analysis of short- and middle-term treatment.
Georgios SchoretsanitisMarjan DrukkerJ Van OsK R J SchruersM BakPublished in: Acta psychiatrica Scandinavica (2018)
The present meta-analysis revealed that sex differences in AP-related weight gain have been under investigated hampering the detection of sex-specific patterns. In chronic patients switching to olanzapine or risperidone receiving short-or middle-term treatment, AP were associated with weight gain in both sex subgroups and no significant differences were reported.
Keyphrases
- weight gain
- birth weight
- body mass index
- systematic review
- end stage renal disease
- weight loss
- preterm infants
- gestational age
- transcription factor
- chronic kidney disease
- ejection fraction
- physical activity
- randomized controlled trial
- polycystic ovary syndrome
- metabolic syndrome
- peritoneal dialysis
- insulin resistance
- meta analyses
- skeletal muscle
- pregnancy outcomes
- cervical cancer screening
- atomic force microscopy